cabozantinib,atezolizumab
roche
['contact03', 'kudos', 'roche,(-broche),(-rocheter)']
1/ results from #contact03 are out both #asco23 and . the 1 st phase 3 trial to assess the efficacy of rechallenge with anti-pdl1 in any cancer type.
kudos to , sc members, , our patients, = for this phenomenal job. 
Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow